Histopathologic Examination of Axillary Sentinel Lymph Nodes in Breast Carcinoma Patients

Journal of Surgical Oncology

Volumn 85, Issue 3, 2004, Pages 123-128

  Viale, Giuseppe ^a,b   Sonzogni, Angelica ^b   Pruneri, Giancarlo ^b   Maffini, Fausto ^b   Masullo, Michele ^b   Dell'Orto, Patrizia ^b   Mazzarol, Giovanni ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Breast cancer; Histopathology; Sentinel lymph node biopsy

Indexed keywords

AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER CYTODIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC ERROR; FOOD FREEZING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; ISOTOPE LABELING; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; MORBIDITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK; SENTINEL LYMPH NODE BIOPSY; STANDARDIZATION; TISSUE SECTION; TREATMENT PLANNING;

AXILLA; BREAST NEOPLASMS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODES; LYMPHATIC METASTASIS; RISK; SENTINEL LYMPH NODE BIOPSY;

EID: 1542319048     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20024     Document Type: Review

References (37)

1. Giuliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
2. Giuliano AE, Jones RC, Brennan MB, et al.: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350.
3. Turner RR, Ollia DW, Krasne DL, et al.: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271.
4. Veronesi U, Paganelli G, Galimberti V, et al.: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-1867.
5. Krag DN, Weaver DL, Ashikaga T, et al.: The sentinel node in breast cancer: A multicenter validation study. N Engl J Med 1998;339:941-946.
6. Veronesi U, Paganelli G, Viale G, et al.: Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series. J Natl Cancer Inst 1999;91:368-373.
7. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 1990:335:1565-1568.
8. Viale G, Bosari S, Mazzarol G, et al.: Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999;85:2433-2438.
9. van Diest PJ, Borgstein PJ, Ljpers R, et al.: Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 1999;35:14-18.
10. Luini A, Gatti G, Frasson A, et al.: Sentinel lymph node biopsy performed under local anesthesia in patients with early-stage breast carcinoma. Arch Surg 2002;137:1157-1160.
11. Chilosi M, Lestani M, Pedron S, et al.: A rapid immunostaining method for frozen sections, Biotech Histochem 1994:69:235-239.
12. Dowlatshahi K, Fan M, Snider HC, et al.: Lymph node micrometastases front breast carcinoma. Reviewing the dilemma. Cancer 1997;80:1188-1197.
13. Cote RJ, Peterson HF, Chaiwun B, et al.: Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet 1999;354:896-900.
14. Chu KU, Turner RR, Hansen NM, et al.: Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Am Surg 1999:229:536-541.
15. Reynolds C, Mick R, Donohue, JH, et al.: Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999:17:1720-1726.
16. Viale G, Maiorano E, Mazzarol G, et al.: Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001;92:1378-1384.
17. Turner RR, Chu KU, Qi K, et al.: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000;89:574-581.
18. Cserni G: Complete sectioning of axillary senlinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 2002;55:926-931.
19. Hermanek P, Hutter RVP, Sobin LH, et al.: International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999;86:2668-2673.
20. Sobin LH, Wittekind C, editors. UICC TNM Classification of malignant tumours, 6th edn. New York: John Wiley & Sons, 2002.
21. Czerniecki BJ, Scheff AM, Callans LS, et al.: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999;85:1098-1103.
22. Dowlatshahi K, Fan M, Bloom KJ, et al.: Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. Cancer 1999;86:990-995.
23. Pendas S, Dauway E, Cox CE, et al.: Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 1999;65:500-506.
24. Franke WW, Moll R: Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph node, tonsils and spleen. Differentiation 1987:36:145-163.
25. Doglioni C, Dell'Orto P, Zanetti G, et al.: Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions. An immunocytochemical study. Virch Arch A Pathol Anat 1990;416:479-490.
26. Masuda N, Tamaki Y, Sakita I, et al.: Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcription-polymerase chain reaction in breast cancer patients. Clin Cancer Res 2000;6:4176-4185.
27. Bostick PJ, Chatteriee S, Chi DD, et al.: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998;16:2632-2640.
28. Bostick PJ, Huynh KT, Sarantou T, et al.: Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer 1998;79:645-651.
29. Kataoka A, Mori M, Sadanaga N, et al.: RT-PCR detection of breast cancer cells in sentinel lymph nodes. Int J Oncol 2000:16:1147-1152.
30. Manzotti M, Dell'Orto P, Maisonneuve P, et al.: Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int J Cancer 2001;95:307-312.
31. Carter BA, Jensen RA, Simpson JF, et al.: Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 2000;113:259-265.
32. Chiu A, Hoda SA, Yao DX, et al.: A potential source of falsepositive sentinel nodes. Immunostain misadventure. Arch Pathol Lab Med 2001;125:1497-1499.
33. Maiorano E, Mazzarol M, Pruneri G, et al.: Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies. Am J Surg Pathol 2003;27:513-518.
34. Edlow DW, Carter D: Heterotopic epithelium in axillary lymph nodes: Report of a case and review of the literature. Am J Clin Pathol 1973;59:666-673.
35. Fisher CJ, Hill S, Millis RR: Benign lymph node inclusions mimicking metastatic carcinoma. J Clin Pathol 1994;47:245-247.
36. Holdsworth PJ, Hopkinson JM, Leveson SH: Benign axillary epithelial lymph node inclusions-a histological pitfall. Histopathology 1988;13:226-228.
37. Turner DR, Millis RR: Breast tissue inclusion in axillary lymph nodes. Histopathology 1980;4:631-636.